16,407views
00:00 / 00:00
de completadas
de completadas
2024
2023
2022
2021
Streptococcus agalactiae p. , 135
Streptococcus agalactiae in p. 135
Streptococcus agalactiae p. , 135
Streptococcus agalactiae in p. 135
Streptococcus agalactiae as cause p. 135
β -hemolytic nature of p. 133
encapsulated bacteria p. 125
Gram-positive testing p. 132
immunodeficient patients p. 116
meningitis p. 177
in neonates p. 181
pneumonia p. 176
prophylaxis for p. 194
splenic dysfunction p. 96
With Streptococcus agalactiae sometimes called Strep agalactiae, strepto means a chain, coccus means round shape, and agalactiae literally means “no milk”.
So, Strep agalactiae refers to the round bacteria that grow in chains and that was previously known to infect cattle, resulting in reduced milk production.
Later on, Strep agalactiae was found to also be a human potential pathogen responsible for a number of infections that most commonly affect pregnant women and newborns.
Strep agalactiae are also called Group B Strep – GBS - in Lancefield classification developed by an American microbiologist Rebecca Lancefield.
Ok now, a little bit of microbe anatomy and physiology.
Strep agalactiae has a thick peptidoglycan cell wall, which takes in purple dye when Gram stained - so this is a gram-positive bacteria.
It’s non-motile and doesn’t form spores, and also, it’s a facultative anaerobe, meaning that it can survive in both aerobic and anaerobic environments.
Now, a particular trait of Streptococcus species is that they are catalase negative, meaning they do not produce an enzyme called catalase.
This is unlike other common gram positive cocci, like Staphylococcus, which are catalase positive.
When cultivated on a medium called blood agar, Strep agalactiae colonies cause beta hemolysis, also called complete hemolysis.
That’s because Strep agalactiae makes a toxin called beta-hemolysin, that causes complete lysis of the hemoglobin in the red blood cells, making them blood agar change color from red to transparent yellow around the colonies.
However, other Streptococcus species, like Strep pyogenes, are also beta hemolytic.
So to identify Strep agalactiae specifically, the bacitracin test, the hippurate test, or the CAMP test can be done.
With the bacitracin test, a disk of bacitracin is added to the blood agar.
Strep agalactiae is bacitracin resistant, so the colonies remain intact, whereas Strep pyogenes is bacitracin sensitive, so the colonies die off.
With the CAMP test, Strep agalactiae is grown with Staphylococcus aureus on the same blood agar.
Both these bacteria are beta-hemolytic, but Strep agalactiae makes a substance called CAMP factor, which enhances the action of staphylococcal beta-hemolysin.
This results in greater areas of beta-hemolysis where these colonies cross each other on the blood agar plate.
Finally, the hippurate test is based on the fact that Strep agalactiae is the only hippurate positive Strep, because it produces an enzyme called hippuricase or hippurate hydrolase.
To test for this, a colony of bacteria is transferred from the culture to a test tube containing a special hippurate medium, and incubated for two hours. Then, a few drops of a substance called ninhydrin are added to the mix.
Streptococcus agalactiae, also known as group B streptococcus, is a gram-positive, beta-hemolytic, catalase-negative, and bacitracin-resistant bacterium, which can cause several infections in humans. Most frequently, Streptococcus agalactiae causes neonatal infections like pneumonia, sepsis, meningitis, and septic arthritis. It can also cause chorioamnionitis or cystitis in pregnant females. Treatment involves antibiotics like penicillin G or ampicillin, or Cefazolin and Vancomycin. To prevent Streptococcus agalactiae infections in neonates, intrapartum antibiotic prophylaxis can be administered to vaginally colonized pregnant females.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.